Recent developments in approved and oral multiple sclerosis treatment and an update on future treatment options
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference114 articles.
1. Multiple sclerosis;Noseworthy;N. Engl. J. Med.,2000
2. Estimation of the cost of MS in Europe: extrapolations from a multinational cost study;Sobocki;Mult. Scler.,2007
3. Magnetic resonance imaging effects of interferon beta-1b in the BENEFIT study: integrated 2-year results;Barkhof;Arch. Neurol.,2007
4. Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group;Johnson;Neurology,1995
5. Physical trauma and multiple sclerosis;Sibley;Neurology,1993
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A novel combination approach to effectively reduce inflammation and neurodegeneration in multiple sclerosis models;Neurochemistry International;2024-05
2. Managing Neuropathic Pain in Multiple Sclerosis: Pharmacological Interventions;Medicinal Chemistry;2018-02-06
3. Dalfampridine: Review on its recent development for symptomatic improvement in patients with multiple sclerosis;Arabian Journal of Chemistry;2016-11
4. Mechanisms of remyelination: recent insight from experimental models;Biomolecular Concepts;2014-08-01
5. Effects of a novel orally administered calpain inhibitor SNJ-1945 on immunomodulation and neurodegeneration in a murine model of multiple sclerosis;Journal of Neurochemistry;2014-02-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3